Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading

Significance Growing experimental evidence suggests that the pathological spreading of alpha-synuclein aggregates in Parkinson’s disease is mediated through a process of templated seeding whereby aggregates catalyze the conversion of soluble protein molecules into their aggregated forms. A molecular-level understanding of this process is still lacking. Here, we determine the concentrations and numbers of aggregates necessary for the effective seeding of alpha-synuclein, thus providing a quantitative framework to understand the conditions when its seeded propagation is favorable. We find that high concentrations of aggregates are needed for seeding yet that aggregates cause cytotoxicity at significantly lower concentrations. This suggests that templated seeding is unlikely to be the main mechanism of spreading in Parkinson’s disease but occurs together with oligomer-induced cellular stress. The protein alpha-synuclein (αS) self-assembles into small oligomeric species and subsequently into amyloid fibrils that accumulate and proliferate during the development of Parkinson’s disease. However, the quantitative characterization of the aggregation and spreading of αS remains challenging to achieve. Previously, we identified a conformational conversion step leading from the initially formed oligomers to more compact oligomers preceding fibril formation. Here, by a combination of single-molecule fluorescence measurements and kinetic analysis, we find that the reaction in solution involves two unimolecular structural conversion steps, from the disordered to more compact oligomers and then to fibrils, which can elongate by further monomer addition. We have obtained individual rate constants for these key microscopic steps by applying a global kinetic analysis to both the decrease in the concentration of monomeric protein molecules and the increase in oligomer concentrations over a 0.5–140-µM range of αS. The resulting explicit kinetic model of αS aggregation has been used to quantitatively explore seeding the reaction by either the compact oligomers or fibrils. Our predictions reveal that, although fibrils are more effective at seeding than oligomers, very high numbers of seeds of either type, of the order of 104, are required to achieve efficient seeding and bypass the slow generation of aggregates through primary nucleation. Complementary cellular experiments demonstrated that two orders of magnitude lower numbers of oligomers were sufficient to generate high levels of reactive oxygen species, suggesting that effective templated seeding is likely to require both the presence of template aggregates and conditions of cellular stress.

[1]  C. Dobson,et al.  Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson’s disease genetically related mutants , 2015, Scientific Reports.

[2]  C. Dobson,et al.  Fast flow microfluidics and single-molecule fluorescence for the rapid characterization of α-synuclein oligomers. , 2015, Analytical chemistry.

[3]  Mathew H Horrocks,et al.  A mechanistic model of tau amyloid aggregation based on direct observation of oligomers , 2015, Nature Communications.

[4]  C. Dobson,et al.  Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation , 2015, Proceedings of the National Academy of Sciences.

[5]  C. Dobson,et al.  Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation. , 2015, Nature chemical biology.

[6]  Vivek K Unni,et al.  Progressive aggregation of alpha-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism , 2015, Cell reports.

[7]  A. Jeans,et al.  Is Parkinson's Disease Truly a Prion-Like Disorder? An Appraisal of Current Evidence , 2015, Neurology research international.

[8]  Thomas G. Beach,et al.  Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry , 2014, Scientific Reports.

[9]  Michele Vendruscolo,et al.  Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation , 2014, Proceedings of the National Academy of Sciences.

[10]  C. Dobson,et al.  Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage , 2014, Biochemistry.

[11]  C. Dobson,et al.  Nucleation-conversion-polymerization reactions of biological macromolecules with prenucleation clusters. , 2014, Physical review. E, Statistical, nonlinear, and soft matter physics.

[12]  Alexander K. Buell,et al.  The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. , 2014, Journal of the American Chemical Society.

[13]  S. Jackson,et al.  Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers. , 2013, Journal of molecular biology.

[14]  T. Yao,et al.  Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains. , 2013, Molecular cell.

[15]  D. Borchelt,et al.  Thinking laterally about neurodegenerative proteinopathies. , 2013, The Journal of clinical investigation.

[16]  Masato Hasegawa,et al.  Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.

[17]  J. Trojanowski,et al.  Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.

[18]  S. Prusiner,et al.  A Unifying Role for Prions in Neurodegenerative Diseases , 2012, Science.

[19]  Christopher M. Dobson,et al.  Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.

[20]  J. Trojanowski,et al.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.

[21]  Mathew H Horrocks,et al.  Single molecule fluorescence under conditions of fast flow. , 2012, Analytical chemistry.

[22]  Michele Vendruscolo,et al.  Metastability of native proteins and the phenomenon of amyloid formation. , 2011, Journal of the American Chemical Society.

[23]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. , 2011, The Journal of chemical physics.

[24]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. , 2011, The Journal of chemical physics.

[25]  Brit Mollenhauer,et al.  α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study , 2011, The Lancet Neurology.

[26]  T. Iwatsubo,et al.  Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. , 2010, The Journal of biological chemistry.

[27]  S. Lindquist,et al.  α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.

[28]  Michael Wolff,et al.  Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology , 2009, Journal of neurochemistry.

[29]  O. Lindvall,et al.  Research in motion: the enigma of Parkinson's disease pathology spread , 2008, Nature Reviews Neuroscience.

[30]  T. Jovin,et al.  Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein. , 2008, Journal of molecular biology.

[31]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[32]  B. Jeon,et al.  α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.

[33]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[34]  David Klenerman,et al.  Optimized threshold selection for single-molecule two-color fluorescence coincidence spectroscopy. , 2007, Analytical chemistry.

[35]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[36]  Richard W. Clarke,et al.  Determination of the fraction and stoichiometry of femtomolar levels of biomolecular complexes in an excess of monomer using single-molecule, two-color coincidence detection. , 2006, Analytical chemistry.

[37]  A. Fink The Aggregation and Fibrillation of α-Synuclein , 2006 .

[38]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[39]  A. Fink The aggregation and fibrillation of alpha-synuclein. , 2006, Accounts of chemical research.

[40]  N. Bonini,et al.  Snaring the Function of α-Synuclein , 2005, Cell.

[41]  J. Hardy,et al.  Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration. , 2005, Biochemical Society transactions.

[42]  N. Bonini,et al.  Snaring the function of alpha-synuclein. , 2005, Cell.

[43]  C. Dobson Protein folding and misfolding , 2003, Nature.

[44]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[45]  Jie Li,et al.  The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability, and Fibril Formation* , 2003, Journal of Biological Chemistry.

[46]  Shu-Bing Qian,et al.  Quantitating protein synthesis, degradation, and endogenous antigen processing. , 2003, Immunity.

[47]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[48]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[49]  V. Subramaniam,et al.  Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .

[50]  V. Subramaniam,et al.  Dependence of alpha-synuclein aggregate morphology on solution conditions. , 2002, Journal of molecular biology.

[51]  J. George,et al.  The synucleins , 2001, Genome Biology.

[52]  Liming Ying,et al.  Ratiometric Analysis of Single-Molecule Fluorescence Resonance Energy Transfer Using Logical Combinations of Threshold Criteria: A Study of 12-mer DNA , 2000 .

[53]  L. Serpell,et al.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Zhang Ming,et al.  Bioenergetic and Oxidative Stress in Neurodegenerative Diseases , 2000 .

[55]  M. Citron,et al.  alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.

[56]  E. Masliah,et al.  Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro , 1999 .

[57]  E. Masliah,et al.  Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. , 1999, Neuroreport.

[58]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[59]  R A Crowther,et al.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.

[60]  P. Lansbury Structural Neurology: Are Seeds at the Root of Neuronal Degeneration? , 1997, Neuron.

[61]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[62]  Fumio Oosawa,et al.  Thermodynamics of the polymerization of protein , 1975 .